Medical weight loss is a busy and increasingly noisy category. Patients arrive with strong opinions about Wegovy, Zepbound, compounded semaglutide, and tirzepatide from Reddit threads and TikTok videos, then ask your clinic which one is right for them. SleekAI is configured to redirect that energy. It explains your published program tiers and inclusion criteria from wp_posts and wp_postmeta, walks through the required labs (CMP, lipid panel, HbA1c, TSH, sometimes a fasting insulin), and shows the monthly cost stack honestly. It does not recommend a medication or dose for the individual.

Your tiers are typically a lifestyle and accountability track at a lower monthly rate, a phentermine or naltrexone-bupropion supervised track in the middle, and a GLP-1 track at the top with brand or compounded options. The bot quotes what each costs, what visits are included, what telehealth coverage looks like for follow-ups, and which states you can prescribe in. It pulls the patient questionnaire link, the lab order step, and the supervising physician's calendar through SimplePractice, Jane App, or your custom scheduler.

The clinical guardrails are firm. The bot refuses dose, titration, side-effect management, contraindication, and combination questions. It surfaces the medical consult booking and the on-call clinical line. Conversations log with model, tokens, and origin page so the medical director audits both the refusal coverage and the program-tier accuracy each month.

The GLP-1 boom has reshaped what a medical weight loss website has to handle. Search volume for Wegovy, Zepbound, and compounded semaglutide has redirected the average inquiry from a general motivation conversation to a specific medication conversation, often led by a patient who has already done six hours of independent research. The clinic that wins that conversation is the one that respects how informed the patient is while being clear that medication choice is a prescriber decision after labs and intake.

A generic chatbot tends to do the opposite. It confidently recommends Wegovy, quotes a price that drifted last quarter, has no idea which states the clinic prescribes in, and either misses or overstates the compounded pathway. The damage shows up as either lost intake or worse, a patient walking in expecting a script that the prescriber will not actually write.

SleekAI keeps the conversation specific and honest. It compares your tracks with current numbers, explains the lab and intake flow, refuses individual medication and dose questions cleanly, and books the consult into the same SimplePractice or Jane App slot your team already runs. The medical director sees the full conversation log every month and the prompt evolves with the program.

The compliance footprint stays small because the bot deliberately collects intent rather than PHI.